TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer. February 22, 2008